Clinical Trial Update: A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase II trial evaluating BMS-986504 in MTAP-deleted pancreatic cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• BMS-986504

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Phase 2 Study, BMS-986504 | Phase 2 | Status: RECRUITING